April 2, 2026 — This article has been disseminated on behalf of Wheaton Precious Metals Corp. and may include paid advertising.
April 2, 2026 — Large-scale layoffs in the technology sector are no longer unusual. What has shifted is how company leaders explain them.
April 2, 2026 — A recently published report by Mordor Intelligence analyzes future projections, growth drivers and the key trends that are shaping the rapidly growing market for cancer immunotherapy. The report puts the valuation of this market in 2025 at $144.
April 2, 2026 — A recent survey has revealed a major gap in how cryptocurrency users understand taxes, raising concerns about compliance and the future growth of the industry. The report, conducted by Coinbase in partnership with CoinTracker, shows that many investors are still confused about basic tax rules related to digital assets.
April 2, 2026 — Gold and silver prices moved higher in early trading at the start of the week. This comes as investors continue to purchase these precious metals in a bid to safeguard their wealth as the conflict in the Middle East rages on.
April 2, 2026 — The ongoing Iran war has led many AI industry watchers and investors to start getting concerned about whether this conflict could push the industry over the edge and cause what many call “the AI bubble” to burst. Several developments have led these grim predictions to seem credible to many.
April 2, 2026 — The crypto market is holding near a $2. 32 trillion market cap, showing little change compared with last week.
April 2, 2026 — This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising.
April 2, 2026 — Solar power has surged from supplying 1% of global electricity in 2015 to roughly 10% today, outpacing nuclear generation and growing faster than any other energy source this century. Worldwide capacity reached approximately 2,900 gigawatts in 2025, and if current expansion rates continue, installations could hit 9,000 gigawatts by 2030, meeting over 20% of planetary energy demand.
April 2, 2026 — Used electric vehicles are suddenly the most searched category in Australia’s second-hand car market, and the timing is no coincidence. Fuel costs have crossed thresholds that are genuinely changing purchase behavior.
April 2, 2026 — Olenox Industries (NASDAQ: OLOX) announced stockholders approved multiple corporate actions at its March 31, 2026 annual meeting, including the election of directors, ratification of its independent auditor, executive compensation on an advisory basis, several share issuance proposals and amendments to increase authorized shares and expand the company’s stock incentive plan. Stockholders also approved a potential reverse stock split at a ratio between 1-for-10 and 1-for-20, while rejecting the proposed merger agreement with New Asia Holdings and related preferred stock conversion.
April 2, 2026 — Oncotelic Therapeutics (OTCQB: OTLC) announced a strategic partnership with TechForce Robotics to advance commercialization of its PDAOAI-enabled, GMP-compliant robotics platform designed for pharmaceutical manufacturing and regulated environments. The integrated system combines Oncotelic’s proprietary AI capabilities with TechForce’s robotics and manufacturing expertise to enable automated material handling, real-time monitoring and compliance workflows, with scalability for broader deployment, as the companies move forward under a joint development, manufacturing and licensing agreement to address growing demand for intelligent, compliant automation solutions.
April 2, 2026 — Xeriant (OTCQB: XERI) announced the U. S.
April 2, 2026 — Disseminated on behalf of Ucore Rare Metals Inc. (TSX.
April 2, 2026 — Wheaton Precious Metals Corp. (WPM)This article has been disseminated on behalf of Wheaton Precious Metals Corp.
April 2, 2026 — Soligenix (NASDAQ: SNGX) announced the publication of positive results from its comparability study evaluating HyBryte(TM) versus Valchlor(R) for the treatment of cutaneous T-cell lymphoma in Oncology and Therapy, highlighting favorable efficacy and safety outcomes. After 12 weeks, 60% of HyBryte-treated patients achieved treatment success compared to 20% for Valchlor, with greater average improvement and no treatment-related adverse events reported for HyBryte, while Valchlor patients experienced multiple adverse reactions, supporting HyBryte’s potential as a well-tolerated therapy for early-stage CTCL.
April 2, 2026 — This article has been disseminated on behalf of Planet Ventures Inc. and may include paid advertising.
April 2, 2026 — This article has been disseminated on behalf of NurExone Biologic and may include paid advertising. NurExone Biologic (TSX.
April 2, 2026 — American Fusion (OTC: AMFN) reported it is in the final stages of securing multi-year supply agreements with a U. S.
April 2, 2026 — This article has been disseminated on behalf of MAX Power Mining and may include paid advertising. MAX Power Mining (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) reported a series of milestones advancing the scale and commercial potential of its Saskatchewan-based Natural Hydrogen portfolio, including successful drilling at the Bracken Well, completion of a high-resolution 3D seismic survey at the Lawson Discovery and surrounding area, and identification of a new Lawson-style target 12 km southwest of the original discovery.